SOLYMBIC
DEAD

Serial Number

88901543

Owner

AMGEN INC.

Attorney

Elsa D. Lemoine

Filing Date

May 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SOLYMBIC Trademark

Serial Number: 88901543

SOLYMBIC is a trademark filed by AMGEN INC. on May 5, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

AMGEN INC. (819 trademarks)

THOUSAND OAKS, CA 91320

Entity Type: 03

Trademark Details

Filing Date

May 5, 2020

Registration Date

Not Registered

Published for Opposition

July 21, 2020

Goods & Services

Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 17, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 17, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2022 EXRA
SOU EXTENSION 4 GRANTED
Sep 15, 2022 EX4G
SOU EXTENSION 4 FILED
Sep 15, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2022 EXRA
SOU EXTENSION 3 GRANTED
Mar 15, 2022 EX3G
SOU EXTENSION 3 FILED
Mar 15, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 12, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 12, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 12, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 15, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 15, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 15, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 29, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2020 CNEA
ASSIGNED TO EXAMINER
May 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2020 NWOS
NEW APPLICATION ENTERED
May 8, 2020 NWAP